Deadline Alert: Erasca, Inc. (ERAS) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

Erasca, Inc. faces a securities fraud class action lawsuit after disclosing a patent infringement allegation from Revolution Medicines on April 27, 2026, followed by a patient death in its ERAS-0015 Phase 1 trial on April 28, 2026. The stock plummeted 48.3% on April 28 after the death disclosure. The lawsuit alleges the company made materially false statements about ERAS-0015's preclinical data and failed to disclose material risks. The deadline to file a lead plaintiff motion is August 10, 2026.